Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01276002

Evaluation of Pancreatic Duct Stenting in Patients With Pancreatic Pseudocysts.

Randomized Multicenter Study on Pancreatic Duct Stenting in Disrupted or Obstructed Ducts in Context With Endoscopic Treatment of Pancreatic Pseudocysts.

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University Hospital Schleswig-Holstein · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The disruption of the pancreatic duct seems to be a major cause pseudocyst formation and persistence in patients suffering from acute/chronic pancreatitis. No prospective randomized studies have been conducted on the influence of pancreatic duct stenting for the patients' benefits and recurrence rates. The aim fo this study is therefore to evaluate prospectively in a randomized, controlled fashion in patients wit pancreatic pseudocysts, wether pancreatic duct stenting of a disrupted pancreatic duct is beneficial in terms of quicker clinical recovery and avoidance of recurrence of pancreatic pseudocysts.

Conditions

Interventions

TypeNameDescription
PROCEDUREpancreatic duct stentingin case of a disrupted pancreatic duct, patients will undergo pancreatic duct stenting.

Timeline

Start date
2011-01-01
Primary completion
2016-12-01
Completion
2016-12-01
First posted
2011-01-13
Last updated
2022-07-06

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01276002. Inclusion in this directory is not an endorsement.